Get startedLog in
    Picture of Torrent Pharmaceuticals logo

    TORNTPHARM — Torrent Pharmaceuticals Cashflow Statement

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareConservativeLarge CapHigh Flyer
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Torrent Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    C2021
    March 31st
    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    2025
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSPRESS
    Standards:
    IAS
    IAS
    IAS
    IAS    		—
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line15,26312,25918,47223,52126,730
    Depreciation
    Non-Cash Items3,3516,8782,3071,8572,010
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital-5,138-7,729-3,574-800-10,840
    Change in Accounts Receivable
    Change in Inventories
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities20,05418,03024,27032,66125,850
    Capital Expenditures-3,352-2,026-5,739-4,328-6,110
    Purchase of Fixed Assets
    Other Investing Cash Flow Items-1,14359.4-18,4142,649710
    Acquisition of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-4,494-1,966-24,153-1,679-5,400
    Financing Cash Flow Items-3,561-2,577-3,030-3,710-2,620
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-16,508-17,811774-27,796-22,980
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-893-1,7421,1013,266-2,620